Patents expiring in 2036

US 9453072

Anti-IL-33 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453028

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453019

Linked purine pterin HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452175

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452221

Poly(acrylate) polymers for in vivo nucleic acid delivery

Arrowhead Pharmaceuticals, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453239

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452163

Abuse resistant pharmaceutical compositions

RECRO GAINESVILLE LLC · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453220

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders

Arrowhead Pharmaceuticals, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453078

Modified antibody compositions, methods of making and using thereof

CytomX Therapeutics, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452186

Enhanced stem cell composition

Fate Therapeutics, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452161

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452182

Collateral gene inactivation biomarkers and targets for cancer therapy

The Board of Regents of the University of Texas System · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452215

Bourvadin derivatives and therapeutic uses thereof

The Regents of the University of Colorado · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452964

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9452973

Modulators of the relaxin receptor 1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453068

Antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453051

Cyclosporin derivatives

Lead Discovery Center GmbH · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453222

Ligand-conjugated monomers

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

DE 202016005375

Verminderung der Deallylierung von Naloxon während der Lagerung einer naloxonhaltigen Retardformulierung

ACINO PHARMA AG [CH] · Granted Fri Sep 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Sep 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457068

Sialylated glycoprotein compositions and uses thereof

Ultragenyx Pharmaceutical Inc. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457103

Adeno-associated virus virions with variant capsid and methods of use thereof

The Regents of the University of California · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457132

Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458086

Compositions and methods for adipocyte modulation

The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024) · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458178

Spiro-oxindole compounds and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458132

Therapeutic compounds and compositions and their use as PKM2 modulators

Agios Pharmaceuticals, Inc. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458166

Oligomer-opioid agonist conjugates

Nektar Therapeutics · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458507

Antipsychotic treatment based on SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9456988

Swallowable drug delivery device and methods of drug delivery

Rani Therapeutics, LLC · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458517

Adeno-associated virus virions with variant capsid and methods of use thereof

The Regents of the University of California · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458442

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

HALOZYME, INC. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458141

Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457070

Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457065

Methods for delivering insulin preparations into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9456997

Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458095

Oligo-benzamide compounds and their use in treating cancers

The Board of Regents of the University of Texas System · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458225

Method for purifying lactoferrin

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9458215

Compositions and methods for osteogenic gene therapy

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457030

Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457002

Antimicrobial compositions comprising glyceryl nitrates

The Board of Regents of the University of Texas System · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457006

Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract

The Regents of the University of California · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457052

Allograft tolerance induction

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457067

Sialylated glycoprotein compositions and uses thereof

Ultragenyx Pharmaceutical Inc. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9457075

Modified foot and mouth disease virus (FMDV) VP1 capsid protein

The Pirbright Institute · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463216

Poly-glutamic acid anti-anthrax compositions and methods for using the same

The Regents of the University of California · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463233

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463220

Method for inducing twin calving

China Agricultural University · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463232

Vault compositions for immunization

The Regents of the University of California · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463193

Individual 5-fluorouracile dose optimization in folfiri treatment

INSTITUT DE CANCEROLOGIE DE L'OUEST · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)